Gait abnormalities in older adults with transthyretin cardiac amyloidosis

References

• Ruberg FL, Grogan M, Hanna M, et al. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(22):2872–2891. doi: 10.1016/j.jacc.2019.04.003.
   PubMed Web of Science ®Google Scholar
• Smiley DA, Rodriguez CM, Maurer MS. Transthyretin cardiac amyloidosis: an evolution in diagnosis and management of an “old” disease. Cardiol Clin. 2022;40(4):541–558. doi: 10.1016/j.ccl.2022.06.008.
   PubMed Web of Science ®Google Scholar
• Rapezzi C, Quarta CC, Obici L, et al. Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective. Eur Heart J. 2013;34(7):520–528. doi: 10.1093/eurheartj/ehs123.
   PubMed Web of Science ®Google Scholar
• Wajnsztajn Yungher F, Kim A, Boehme A, et al. Peripheral neuropathy symptoms in wild type transthyretin amyloidosis. J Peripher Nerv Syst. 2020;25(3):265–272. doi: 10.1111/jns.12403.
   PubMed Web of Science ®Google Scholar
• Maurer MS, Smiley D, Simsolo E, et al. Analysis of lumbar spine stenosis specimens for identification of amyloid. J Am Geriatr Soc. 2022;70(12):3538–3548. doi: 10.1111/jgs.17976.
   PubMed Web of Science ®Google Scholar
• Sharma B, Gee M, Nelles K, et al. Gait in cerebral amyloid angiopathy. J Am Heart Assoc. 2022;11:e025886.
   PubMed Web of Science ®Google Scholar
• Vilas-Boas MDC, Fonseca PFP, Sousa IM, et al. Gait characterization and analysis of hereditary amyloidosis associated with transthyretin patients: a case series. J Clin Med. 2022;11:3967.
   PubMed Web of Science ®Google Scholar
• Vilas-Boas MDC, Rocha AP, Cardoso MN, et al. Supporting the assessment of hereditary transthyretin amyloidosis patients based on 3-D gait analysis and machine learning. IEEE Trans Neural Syst Rehabil Eng. 2021;29:1350–1362. doi: 10.1109/TNSRE.2021.3096433.
   PubMed Web of Science ®Google Scholar
• Vilas-Boas MDC, Rocha AP, Cardoso MN, et al. Clinical 3-D gait assessment of patients with polyneuropathy associated with hereditary transthyretin amyloidosis. Front Neurol. 2020;11:605282. doi: 10.3389/fneur.2020.605282.
   PubMed Web of Science ®Google Scholar
• Carmo Vilas-Boas MD, Patricia Rocha A, Pereira Choupina HM, et al. TTR-FAP progression evaluation based on gait analysis using a single RGB-D camera. Annu Int Conf IEEE Eng Med Biol Soc. 2019;2019:5494–5497.
   PubMedGoogle Scholar
• Vilas-Boas MDC, Rocha AP, Choupina HMP, et al. Validation of a single RGB-D camera for gait assessment of polyneuropathy patients. Sensors. 2019;19(22):4929. doi: 10.3390/s19224929.
   PubMed Web of Science ®Google Scholar
• Do Carmo Vilas-Boas M, Rocha AP, et al. The first transthyretin familial amyloid polyneuropathy gait quantification study – preliminary results. Annu Int Conf IEEE Eng Med Biol Soc. 2017;2017:1368–1371.
   PubMedGoogle Scholar
• Irabor B, McMillan JM, Fine NM. Assessment and management of older patients with transthyretin amyloidosis cardiomyopathy: geriatric cardiology, frailty assessment and beyond. Front Cardiovasc Med. 2022;9:863179. doi: 10.3389/fcvm.2022.863179.
   PubMed Web of Science ®Google Scholar
• Bouche P. Neuropathy of the elderly. Rev Neurol. 2020;176(9):733–738. doi: 10.1016/j.neurol.2019.11.007.
   PubMedGoogle Scholar
• Basdavanos A, Maurer MS, Ives L, et al. Prevalence of orthopedic manifestations in patients with cardiac amyloidosis with a focus on shoulder pathologies. Am J Cardiol. 2022;190:67–74. doi: 10.1016/j.amjcard.2022.11.014.
   PubMed Web of Science ®Google Scholar
• Rubin J, Alvarez J, Teruya S, et al. Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier? Amyloid. 2017;24(4):226–230. doi: 10.1080/13506129.2017.1375908.
   PubMed Web of Science ®Google Scholar
• Dorbala S, Ando Y, Bokhari S et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2019;26:2065–2123.
   Google Scholar
• Dorbala S, Ando Y, Bokhari S et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-evidence base and standardized methods of imaging. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2019;26:2065–2123.
   Google Scholar
• Muir-Hunter SW, Wittwer JE. Dual-task testing to predict falls in community-dwelling older adults: a systematic review. Physiotherapy. 2016;102(1):29–40. doi: 10.1016/j.physio.2015.04.011.
   PubMed Web of Science ®Google Scholar
• Bayot M, Dujardin K, Dissaux L, et al. Can dual-task paradigms predict falls better than single task? A systematic literature review. Neurophysiol Clin. 2020;50(6):401–440. doi: 10.1016/j.neucli.2020.10.008.
   PubMed Web of Science ®Google Scholar
• Cheng RK, Levy WC, Vasbinder A, et al. Diuretic dose and NYHA functional class are independent predictors of mortality in patients with transthyretin cardiac amyloidosis. JACC CardioOncol. 2020;2(3):414–424. doi: 10.1016/j.jaccao.2020.06.007.
   PubMedGoogle Scholar
• Iglewicz B, Hoaglin DC. How to detect and handle outliers. Milwaukee, Wisconsin: Quality Press; 1993. p. 16.
   Google Scholar
• Forman DE, Alexander K, Brindis RG, et al. Improved cardiovascular disease outcomes in older adults. F1000Res. 2016;5:112. doi: 10.12688/f1000research.7088.1.
   Google Scholar
• Papathanasiou M, Jakstaite AM, Oubari S, et al. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis. ESC Heart Fail. 2022;9(3):1740–1748. doi: 10.1002/ehf2.13851.
   PubMed Web of Science ®Google Scholar
• Kittleson MM, Ruberg FL, Ambardekar AV, et al. 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023;81(11):1076–1126. doi: 10.1016/j.jacc.2022.11.022.
   PubMed Web of Science ®Google Scholar
• Kittleson MM, Maurer MS, Ambardekar AV, et al. Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association. Circulation. 2020;142(1):e7–e22. doi: 10.1161/CIR.0000000000000792.
   PubMed Web of Science ®Google Scholar
• Garcia-Pavia P, Rapezzi C, Adler Y, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on myocardial and pericardial diseases. Eur Heart J. 2021;42(16):1554–1568. doi: 10.1093/eurheartj/ehab072.
   PubMed Web of Science ®Google Scholar
• DeSimone CV, Graff-Radford J, El-Harasis MA, et al. Cerebral amyloid angiopathy: diagnosis, clinical implications, and management strategies in atrial fibrillation. J Am Coll Cardiol. 2017;70(9):1173–1182. doi: 10.1016/j.jacc.2017.07.724.
   PubMed Web of Science ®Google Scholar
• Patel D, Ackermann RJ. Issues in geriatric care: falls. FP Essent. 2018;468:18–25.
   PubMedGoogle Scholar
• Iolascon G, de Sire A, Calafiore D, et al. Multifactorial assessment of risk of falling in 753 post-menopausal women: a multicenter cross-sectional study by the Italian group for the study of metabolic bone diseases. Clin Interv Aging. 2020;15:1077–1084. doi: 10.2147/CIA.S257304.
   PubMed Web of Science ®Google Scholar
• Pieruccini-Faria F, Montero-Odasso M, Hausdorff JM. Gait variability and fall risk in older adults: the role of cognitive function. In: Montero-Odasso, M, Camicioli, R, editor, Falls and cognition in older persons: fundamentals, assessment and therapeutic options; Springer, Cham; 2020. p. 107–138. https://doi.org/10.1007/978-3-030-24233-6_7
   Google Scholar
• Brach JS, Berlin JE, VanSwearingen JM, et al. Too much or too little step width variability is associated with a fall history in older persons who walk at or near normal gait speed. J Neuroeng Rehab. 2005;2(1):21. doi: 10.1186/1743-0003-2-21.
   PubMedGoogle Scholar